ArticleCurrent oncology (Toronto, Ont.)2026

First-Line Pembrolizumab Monotherapy for Advanced Non-Small Cell Lung Cancer: A Multicenter Real-World Study from Vietnam.

Thi Huong Pham et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.